TrialJournal of child and adolescent psychopharmacology2013

Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

Linda Wietecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.